Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Third U.S. patent on Teva's MS drug Copaxone invalidated
Third U.S. patent on Teva's MS drug Copaxone invalidated
Third U.S. patent on Teva's MS drug Copaxone invalidated
Submitted by
admin
on September 2, 2016 - 11:29am
Source:
Reuters
News Tags:
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
patents
Headline:
Third U.S. patent on Teva's MS drug Copaxone invalidated
Do Not Allow Advertisers to Use My Personal information
